SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-22-006798
Filing Date
2022-02-25
Accepted
2022-02-25 15:54:15
Documents
9

Document Format Files

Seq Description Document Type Size
1 POS AM ny20001536x2_posam.htm POS AM 1057524
2 EXHIBIT 5.1 ny20001536x2_ex5-1.htm EX-5.1 18869
3 EXHIBIT 23.1 ny20001536x2_ex23-1.htm EX-23.1 1717
4 EXHIBIT 23.2 ny20001536x2_ex23-2.htm EX-23.2 2811
5 logo_abcellerax1.jpg GRAPHIC 37994
6 logo_abcellerax2.jpg GRAPHIC 32295
7 BLAKES LOGO ny20001536x2_ex5-1img01.jpg GRAPHIC 13679
8 BLAKES LETTERHEAD ny20001536x2_ex5-1img02.jpg GRAPHIC 28227
9 BLAKES FOOTER ny20001536x2_ex5-1img03.jpg GRAPHIC 7840
  Complete submission text file 0001140361-22-006798.txt   1247380
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-256998 | Film No.: 22679575
SIC: 2834 Pharmaceutical Preparations